NicholasJRobertMD

Oncology • Fairfax, VA

Breast Cancer, Hematologic Oncology

Virginia Cancer Specialists

Join to view full profile

Dr. Robert is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Robert's full profile

Already have an account?

Office
8503 Arlington Blvd
Ste 400
Fairfax, VA 22031
Phone+1 703-280-5390

Fax+1 703-280-9596
Is this information wrong?

Education & Training

Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1980 - 1981
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1979 - 1980
Massachusetts General HospitalResidency, Pathology-Anatomic and Clinical, 1976 - 1978
McGill University Faculty of MedicineClass of 1974

Certifications & Licensure

VA State Medical License 1991 - 2020
American Board of Pathology Anatomic Pathology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2002-2014
America's Top Doctors for Cancer Castle Connolly, 2005-2013
Top Doctors:Washington-Baltimore Castle Connolly, 2012
Top Doctors:Washington DC Area Castle Connolly, 2012
Northern Virginia Magazine Castle Connolly, 2007-2008
Redbook Magazine: Top Breast Cancer Doctors Castle Connolly, 2001
Top MD Consumers Checkbook
Join now to see all

Clinical Trials

Letrozole After Tamoxifen in Treating Women With Breast Cancer Start of enrollment: 1998 Aug 24
Completed
Phase 3
Everolimus in Combination With Trastuzumab and Paclitaxel in the Treatment of HER2 Positive Locally Advanced or Metastatic Breast Cancer Start of enrollment: 2009 Sep 10
Completed
Phase 3
Study of the Efficacy of Chloroquine in the Treatment of Ductal Carcinoma in Situ (The PINC Trial) Start of enrollment: 2009 Dec 01
Completed
Phase 1, Phase 2
Efficacy and Safety Study of NeuVax™ (Nelipepimut-S or E75) Vaccine to Prevent Breast Cancer Recurrence Start of enrollment: 2011 Nov 01
Completed
Phase 3
Combination Immunotherapy With Herceptin and the HER2 Vaccine NeuVax Start of enrollment: 2013 May 21
Completed
Phase 2
A Pilot Study Utilizing Proteomic and Genomic Profiling for Patients With Metastatic Breast Cancer Start of enrollment: 2013 Aug 01
Completed
Not Applicable
A Study Evaluating Talazoparib (BMN 673), a PARP Inhibitor, in Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (EMBRACA Study) Start of enrollment: 2013 Oct 14
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

2 citations
Genetic Polymorphisms and Correlation with Treatment-Induced Cardiotoxicity and Prognosis in Patients with Breast Cancer.
Parvin F Peddi, Peter A Fasching, Duan Liu, Emmanuel Quinaux, Nicholas J Robert, Vicente Valero, John Crown, Carla Falkson, Adam Brufsky, Julie M Cunningham, Richard M...> ;Clinical Cancer Research. 2022 May 2
18 citations
The Friends of Cancer Research Real-World Data Collaboration Pilot 2.0: Methodological Recommendations from Oncology Case Studies.
Donna Rivera, Henry J. Henk, Elizabeth Garrett-Mayer, Jennifer B. Christian, Andrew J. Belli, Suanna S. Bruinooge, Janet L. Espirito, Connor Sweetnam, Monika A Izano, ...> ;Clinical Pharmacology and Therapeutics. 2021 Nov 11
10 citations
Real-world Overall Survival Using Oncology Electronic Health Record Data: Friends of Cancer Research Pilot.
Laura Lasiter, Olga Tymejczyk, Elizabeth Garrett-Mayer, Shrujal S. Baxi, Andrew J. Belli, Marley Boyd, Jennifer B. Christian, Aaron B Cohen, Janet L. Espirito, Eric Ha...> ;Clinical Pharmacology and Therapeutics. 2021 Nov 2
5 citations
Multi-omic molecular profiling guide's efficacious treatment selection in refractory metastatic breast cancer: a prospective phase II clinical trial.
Mariaelena Pierobon, Nicholas J. Robert, Donald W. Northfelt, Mohammad Jahanzeb, Shukmei Wong, Kimberly A. Hodge, Elisa Baldelli, Jessica Aldrich, David Craig, Lance A...> ;Molecular Oncology. 2021 Sep 12
3 citations
Treatment patterns and outcomes for patients with newly diagnosed glioblastoma multiforme: a retrospective cohort study.
Srinivas Annavarapu, Anagha Gogate, Trang Pham, Kalatu Davies, Prianka Singh, Nicholas J. Robert> ;CNS Oncology. 2021 Sep 1
17 citations
Understanding Contemporary Molecular Biomarker Testing Rates and Trends for Metastatic NSCLC Among Community Oncologists.
David M. Waterhouse, Wan-Yu Tseng, Janet L. Espirito, Nicholas J. Robert> ;Clinical Lung Cancer. 2021 May 29
2 citations
Treatment patterns and outcomes of patients with advanced malignant pleural mesothelioma in a community practice setting.
David M. Waterhouse, E. Nwokeji, Marley Boyd, John R. Penrod, Janet L. Espirito, Nicholas J. Robert, M. Daumont> ;Future Oncology. 2021 Mar 26
11 citations
Recurrence rates in patients with HER2+ breast cancer who achieved a pathological complete response after neoadjuvant pertuzumab plus trastuzumab followed by adjuvant ...
Joyce O'Shaughnessy, Nicholas J. Robert, Srinivas Annavarapu, Jie Zhou, Jesse Sussell, Anna Cheng, Anita Fung> ;Breast Cancer Research and Treatment. 2021 Mar 1
15 citations
Comparisons of Real-World Time-to-Event End Points in Oncology Research.
Brigham Walker, Marley Boyd, Kat Aguilar, Kalatu Davies, Janet L. Espirito, Jennifer Frytak, Nicholas J. Robert> ;JCO Clinical Cancer Informatics. 2021 Jan 7
3 citations
Recommendations to Streamline and Standardize Clinical Trial Site Feasibility Assessments: An ASCO Research Statement
Dax Kurbegov, Patricia Hurley, David M. Waterhouse, Nicholas J. Robert, Grzegorz S. Nowakowski, Michael A. Thompson, Suanna S. Bruinooge, Richard L. Schilsky, Leslie B...> ;JCO Oncology Practice. 2021 Jan 6
12 citations
Retrospective Observational Study of ALK-Inhibitor Therapy Sequencing and Outcomes in Patients with ALK-Positive Non-small Cell Lung Cancer
David M. Waterhouse, Janet L. Espirito, Marc D. Chioda, Bismark Baidoo, Jack Mardekian, Nicholas J. Robert, Elizabeth T. Masters> ;Drugs - Real World Outcomes. 2020 Dec 1
33 citations
Clinical outcomes among unresectable, locally advanced, and metastatic cutaneous squamous cell carcinoma patients treated with systemic therapy
C. Lance Cowey, Nicholas J. Robert, Janet L. Espirito, Kalatu Davies, Jennifer Frytak, Israel Lowy, Matthew G. Fury> ;Cancer Medicine. 2020 Jun 24
6 citations
Evaluation of Practice Patterns Among Oncologists Participating in the Oncology Care Model.
Brigham Walker, Jennifer Frytak, Jad Hayes, Marcus A. Neubauer, Nicholas J. Robert, Lalan S. Wilfong> ;JAMA Network Open. 2020 May 1
Corrections to "Adverse events risk associated with bevacizumab addition to breast cancer chemotherapy: a meta-analysis".
J. Cortés, Virginia Calvo, N. Ramírez-Merino, Joyce A. O'Shaughnessy, Adam Brufsky, Nicholas J. Robert, Maria Vidal, Eva Muñoz, José Francisco Pérez, Shaheenah Dawood,...> ;Annals of Oncology. 2019 Jul 1
29 citations
Outcomes in patients with metastatic bladder cancer in the USA: a retrospective electronic medical record study.
Kyle Flannery, Marley Boyd, Jenny Black-Shinn, Nicholas J Robert, Ashish M. Kamat> ;Future Oncology. 2019 Apr 1
18 citations
PIK3CA alterations and benefit with neratinib: analysis from the randomized, double-blind, placebo-controlled, phase III ExteNET trial.
Stephen Chia, Miguel Martin, Frankie A. Holmes, Bent Ejlertsen, Suzette Delaloge, Beverly Moy, Hiroji Iwata, Gunter von Minckwitz, Janine Mansi, Carlos H. Barrios, Mic...> ;Breast Cancer Research. 2019 Mar 11
5 citations
Treatment According to a Comprehensive Molecular Profiling Can Lead to a Better Outcome in Heavily Pretreated Patients With Metastatic Cancer: Data of a Pooled Analysis.
Andreas Seeber, Georges Chahine, Fadi Nasr, Andrew Dean, Mira Miranova, Gayle S. Jameson, Nicholas J. Robert, Guenther Gastl, Heinz Zwierzina> ;Cancer Journal. 2019 Mar 1
22 citations
Assessment of ERBB2 / HER2 Status in HER2 -Equivocal Breast Cancers by FISH and 2013/2014 ASCO-CAP Guidelines
Michael F. Press, Jose A. Seoane, Christina Curtis, E. Quinaux, Roberta Guzman, Guido Sauter, Wolfgang Eiermann, John R. Mackey, Nicholas J. Robert, Tadeusz Pienkowski...> ;JAMA Oncology. 2019 Mar 1
1 citations
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy in Early-Stage Invasive Breast Cancer.
Joanne L. Blum, Nicholas J. Robert, Jay Andersen, Anne Favret, Patrick J. Ward, Cynthia Osborne, John Pippen> ;Journal of Clinical Oncology. 2017 Dec 11
364 citations
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3...
, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,...> ;The Lancet. Oncology. 2017 Dec 1
7 citations
Patient Case Lessons: Endocrine Management of Advanced Breast Cancer
Nicholas J. Robert, Neelima Denduluri> ;Clinical Breast Cancer. 2017 Jun 6
64 citations
Enrichment of PI3K-AKT-mTOR Pathway Activation in Hepatic Metastases from Breast Cancer.
Mariaelena Pierobon, Corinne Ramos, Shukmei Wong, K. Alex Hodge, Jessica Aldrich, Sara A. Byron, Stephen P. Anthony, Nicholas J. Robert, Donald W. Northfelt, Mohammad ...> ;Clinical Cancer Research. 2017 Aug 15
175 citations
Anthracyclines in early breast Cancer: The ABC Trials—USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 (NRG Oncology)
Joanne L. Blum, Patrick J. Flynn, Greg Yothers, Lina Asmar, Charles E. Geyer, Samuel A. Jacobs, Nicholas J. Robert, Judith O. Hopkins, Joyce O'Shaughnessy, Chau T. Dan...> ;Journal of Clinical Oncology. 2017 Apr 11
22 citations
HER2-Positive Metastatic Breast Cancer Patients Receiving Pertuzumab in a Community Oncology Practice Setting: Treatment Patterns and Outcomes
Nicholas J. Robert, Hans-Peter Goertz, Pooja Chopra, Xiaolong Jiao, Bongin Yoo, Debra A. Patt, Vincent Antao> ;Drugs - Real World Outcomes. 2017 Mar 1
102 citations
HER2 Gene Amplification Testing by Fluorescent In Situ Hybridization (FISH): Comparison of the ASCO-College of American Pathologists Guidelines With FISH Scores Used f...
Michael F. Press, Guido Sauter, Marc Buyse, Hélène Fourmanoir, E. Quinaux, Denice D. Tsao-Wei, Wolfgang Eiermann, Nicholas J. Robert, Tadeusz Pienkowski, J.P. Crown, M...> ;Journal of Clinical Oncology. 2016 Oct 23
Join now to see all

Abstracts/Posters

Treatment Patterns and Outcomes of Patients with Relapsed or Refractory Follicular Lymphoma Treated with Idelalisib in a Community Oncology Setting
Nicholas James Robert, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Press Mentions

Personalized Care in the Community: Making It HappenDecember 19th, 2022
New MYLUNG Consortium Research Demonstrates Remote Pharmacist Intervention Significantly Increases Clinical Trial Enrollments in Community Oncology SettingJune 6th, 2022
Ontada Research Highlights Power of Real-World Oncology Data at ISPOR 2022May 26th, 2022
Join now to see all

Hospital Affiliations

UVA Health Prince William Medical CenterManassas, Virginia